Inactive Instrument
NicOx SA Stock Euronext Paris
Stocks
NCOX
FR0000074130
Pharmaceuticals
OTC Markets Traded| Market Cap | 32.96M 37.64M 30.43M 28.41M 53.49M 3.56B 54.71M 366M 141M 1.76B 141M 138M 6.1B | P/E 2026 * |
37.4x | P/E 2027 * | 3.12x |
|---|---|---|---|---|---|
| Enterprise Value | 32.96M 37.64M 30.43M 28.41M 53.49M 3.56B 54.71M 366M 141M 1.76B 141M 138M 6.1B | EV / Sales 2026 * |
3.3x | EV / Sales 2027 * | 1.65x |
| Free-Float |
99.65% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -7.95% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
CEO | Chief Executive Officer | 55 | 28/02/2024 |
Sandrine Gestin
DFI | Director of Finance/CFO | 58 | 01/01/2015 |
Doug Hubatsch
CTO | Chief Tech/Sci/R&D Officer | - | 13/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
BRD | Director/Board Member | 55 | 08/04/2024 |
Damian Marron
CHM | Chairman | 64 | 16/07/2024 |
Marc Bozec
BRD | Director/Board Member | - | 16/07/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.95% | -9.39% | - | - | 37.64M | |
| -0.87% | +7.21% | +61.98% | +11.12% | 320B | |
| +0.31% | +8.78% | +33.50% | -3.10% | 72.69B | |
| +2.03% | +12.59% | +50.68% | +117.31% | 9.15B | |
| +0.37% | +2.29% | +5.85% | -3.52% | 8.33B | |
| -4.94% | +1.29% | -5.15% | +5.61% | 4.62B | |
| +0.98% | +11.14% | +12.81% | +37.05% | 3.99B | |
| -4.88% | -4.36% | -32.24% | +28.19% | 3.57B | |
| -0.77% | +4.14% | +46.95% | +54.09% | 2.72B | |
| -1.71% | +9.98% | +15.61% | -22.67% | 2.18B | |
| Average | -1.74% | +5.59% | +21.11% | +24.90% | 47.42B | |
| Weighted average by Cap. | -0.64% | +11.80% | +53.48% | +11.11% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10M 11.42M 9.23M 8.62M 16.23M 1.08B 16.6M 111M 42.89M 533M 42.89M 41.95M 1.85B | 20M 22.84M 18.46M 17.24M 32.46M 2.16B 33.2M 222M 85.77M 1.07B 85.78M 83.9M 3.7B |
| Net income | 1M 1.14M 923K 862K 1.62M 108M 1.66M 11.11M 4.29M 53.27M 4.29M 4.19M 185M | 11M 12.56M 10.15M 9.48M 17.85M 1.19B 18.26M 122M 47.18M 586M 47.18M 46.14M 2.03B |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
